- Home
- MAIA vs APT Comparison
MAIA vs APT Comparison
Compare MAIA & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- APT
- Stock Information
- Founded
- MAIA 2018
- APT 1983
- Country
- MAIA United States
- APT Canada
- Employees
- MAIA N/A
- APT N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- APT
- Sector
- MAIA Health Care
- APT
- Exchange
- MAIA Nasdaq
- APT Nasdaq
- Market Cap
- MAIA 52.8M
- APT 61.6M
- IPO Year
- MAIA 2022
- APT 1995
- Fundamental
- Price
- MAIA $2.00
- APT $5.50
- Analyst Decision
- MAIA
- APT
- Analyst Count
- MAIA 0
- APT 0
- Target Price
- MAIA N/A
- APT N/A
- AVG Volume (30 Days)
- MAIA 346.7K
- APT 40.6K
- Earning Date
- MAIA 11-12-2024
- APT 03-12-2025
- Dividend Yield
- MAIA N/A
- APT N/A
- EPS Growth
- MAIA N/A
- APT 20.88
- EPS
- MAIA N/A
- APT 0.37
- Revenue
- MAIA N/A
- APT $59,288,000.00
- Revenue This Year
- MAIA N/A
- APT N/A
- Revenue Next Year
- MAIA N/A
- APT N/A
- P/E Ratio
- MAIA N/A
- APT $14.87
- Revenue Growth
- MAIA N/A
- APT 1.88
- 52 Week Low
- MAIA $1.17
- APT $4.64
- 52 Week High
- MAIA $5.99
- APT $6.92
- Technical
- Relative Strength Index (RSI)
- MAIA 44.72
- APT 50.57
- Support Level
- MAIA $1.97
- APT $5.56
- Resistance Level
- MAIA $2.44
- APT $6.05
- Average True Range (ATR)
- MAIA 0.20
- APT 0.22
- MACD
- MAIA 0.00
- APT 0.00
- Stochastic Oscillator
- MAIA 8.33
- APT 42.11
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.